InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (72 ops.)
Insider track record
ShareholderDisclosed buys
0
Disclosed sells
72
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Ares Trading S.A., Board Member / Significant Shareholder. Insider active across 1 company, notably Precigen, INC.. Aggregated, 72 reports have been recorded. Breakdown: 0 buy · 72 sells. Total volume traded: €41m. History available since 30 April 2021. The latest transaction was filed on 12 October 2021 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations72 total
63,900 shares@ US$4.68660.016% mcap0.6% of flowCommon StockSEC:0001104659-21-126314:0
63,900 shares@ US$4.68660.016% mcap1.3% of flowCommon StockSEC:0001104659-21-126314
47,304 shares@ US$4.69460.012% mcap0.9% of flowCommon StockSEC:0001104659-21-125461
47,304 shares@ US$4.69460.012% mcap0.5% of flowCommon StockSEC:0001104659-21-125461:0
47,800 shares@ US$4.88090.013% mcap0.5% of flowCommon StockSEC:0001104659-21-124738:0
47,800 shares@ US$4.88090.013% mcap1.0% of flowCommon StockSEC:0001104659-21-124738
9,700 shares@ US$5.02060.0027% mcap0.1% of flowCommon StockSEC:0001104659-21-123731:0
9,700 shares@ US$5.02060.0027% mcap0.2% of flowCommon StockSEC:0001104659-21-123731
100 shares@ US$5.100.0000% mcap0.0% of flowCommon StockSEC:0001104659-21-122492:0
100 shares@ US$5.100.0000% mcap0.0% of flowCommon StockSEC:0001104659-21-122492
4,584 shares@ US$6.28570.0015% mcap0.1% of flowCommon StockSEC:0001104659-21-115586:0
4,584 shares@ US$6.28570.1% of flowCommon StockSEC:0001104659-21-115586
2,400 shares@ US$6.23190.0008% mcap0.0% of flowCommon StockSEC:0001104659-21-114763:0
2,400 shares@ US$6.23190.0% of flowCommon StockSEC:0001104659-21-114763
29,065 shares@ US$6.41690.0100% mcap0.4% of flowCommon StockSEC:0001104659-21-113889:0
29,065 shares@ US$6.41690.4% of flowCommon StockSEC:0001104659-21-113889
254,932 shares@ US$6.20983.3% of flowCommon StockSEC:0001104659-21-113025
254,932 shares@ US$6.20980.085% mcap3.3% of flowCommon StockSEC:0001104659-21-113025:0
30,000 shares@ US$5.96830.0096% mcap0.4% of flowCommon StockSEC:0001104659-21-112129:0
30,000 shares@ US$5.96830.4% of flowCommon StockSEC:0001104659-21-112129
111,229 shares@ US$5.9470.036% mcap1.4% of flowCommon StockSEC:0001104659-21-111143:0
111,229 shares@ US$5.9471.4% of flowCommon StockSEC:0001104659-21-111143
33,407 shares@ US$5.86490.4% of flowCommon StockSEC:0001104659-21-109874
33,407 shares@ US$5.86490.011% mcap0.4% of flowCommon StockSEC:0001104659-21-109874:0
52,031 shares@ US$6.19570.7% of flowCommon StockSEC:0001104659-21-107083
25 of 72 declarations
About Ares Trading S.A.
Ares Trading S.A. is best described, in the context of PRECIGEN, INC., as a significant shareholder and strategic counterpart rather than a day-to-day operating executive. Public filings and market data reviewed for Precigen identify Ares Trading S.A. as a substantial holder of the company’s equity, with the most recently located disclosure indicating ownership of roughly 8.3% of Precigen’s outstanding common stock. That level of ownership points to a meaningful governance and capital-markets presence, especially for a U.S.-listed biotechnology company, but it does not by itself establish an executive title such as Chief Executive Officer or Chief Financial Officer. The available sources do not provide a reliable individual biography, nor do they clearly link Ares Trading S.A. to a named operational leader at Precigen. As a result, the safest accurate description is that of a notable strategic investor with influence through ownership and corporate involvement, while avoiding unsupported claims about a personal career path, prior companies led, or specific management decisions.
